Chicago Partners Investment Group LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1563525 CHICAGO, IL

Position in VRTX

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$522,451

+$129,388 QoQ

Shares Held

1,170

+34.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 1.5384615384615385.ToString("F0")% Shared 0.ToString("F0")% None 98.46153846153847.ToString("F0")%

Healthcare · as of Mar 31, 2026

Chicago Partners Investment Group LLC holds $9,972,920 across 37 Biotechnology names. VRTX ranks #8 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,001	$1,546,052
2	INCY	Incyte Corp	8,174	$769,336
3	TSHA	Taysha Gene Therapies, Inc.	170,751	$763,256
4	ASND	Ascendis Pharma A/S	3,054	$698,541
5	EXEL	Exelixis, Inc.	16,204	$694,989
6	BMRN	Biomarin Pharmaceutical Inc	12,183	$688,217
7	JAZZ	Jazz Pharmaceuticals plc	2,861	$540,872
8	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,170	$522,451

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$522,451	1,170	+34.9%	Shares	Sole	2026-05-04
2025-12-31	$393,063	867	-13.9%	Shares	Sole	2026-01-28
2025-09-30	$394,381	1,007	-10.4%	Shares	Sole	2025-10-30
2025-06-30	$500,404	1,124	+18.6%	Shares	Sole	2025-07-29
2025-03-31	$459,609	948	+17.5%	Shares	Sole	2025-05-09
2024-12-31	$324,978	807	+69.9%	Shares	Sole	2025-01-24
2024-09-30	$220,913	475	+6.5%	Shares	Sole	2024-10-29
2024-06-30	$209,049	446	—	Shares	Sole	2024-07-31
No filing history on record for this holder in this stock.